On top of that, PPARβ/δ activation induces the expression of mediators suppressing inflammatory cytokine/chemokine action (RGS, TIMP-3), altogether explaining the beneficialeffects of PPARβ/δ agonists in inflammatory diseases such as atherosclerosis [78, 79]. Here, PPARD is linked to atherosclerosis.